Lentivirus-mediated Silencing of Rhomboid Domain Containing 1 Suppresses Tumor Growth and Induces Apoptosis in Hepatoma HepG2 Cells

  • Liu, Xue-Ni (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Tang, Zheng-Hao (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Zhang, Yi (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Pan, Qing-Chun (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Chen, Xiao-Hua (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Yu, Yong-Sheng (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University) ;
  • Zang, Guo-Qing (Department of Infectious Diseases, Sixth People's Hospital, Shanghai Jiaotong University)
  • Published : 2013.01.31


Rhomboids were identified as the first intramembrane serine proteases about 10 years ago. Since then, the study of the rhomboid protease family has blossomed. Rhomboid domain containing 1 (RHBDD1), highly-expressed in human testis, contains a rhomboid domain with unknown function. In the present study, we tested the hypothesis that RHBDD1 was associated with proliferation and apoptosis in hepatocellular carcinoma using recombinant lentivirus-mediated silencing of RHBDD1 in HepG2 cells. Our results showed that down-regulation of RHBDD1 mRNA levels markedly suppressed proliferation and colony formation capacity of HepG2 human hepatoma cancer cells in vitro, and induced cell cycle arrest. We also found that RHBDD1 silencing could obviously trigger HepG2 cell apoptosis. In summary, it was demonstrated that RHBDD1 might be a positive regulator for proliferative and apoptotic characteristics of hepatocellular carcinoma.


  1. Lemberg MK, Freeman M (2007). Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res, 17, 1634-46.
  2. McQuibban GA, Saurya S, Freeman M (2003). Mitochondrial membrane remodelling regulated by a conserved rhomboid protease. Nature, 423, 537-41.
  3. Sanoff HK, Bernard S, Goldberg RM, et al (2011). Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma. Gastrointest Cancer Res, 4, 78-83.
  4. Sogawa C, Tsuji AB, Yoshida C, et al (2012). Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma. Nucl Med Commun, 33, 719-25.
  5. Urban S, Lee JR, Freeman M (2001). Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell, 107, 173-82.
  6. Wang Y, Guan X, Fok KL, et al (2008). A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis. Cell Mol Life Sci 65, 3822-9.
  7. Weihofen A, Martoglio B (2003). Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Cell Biol, 13, 71-8.
  8. Wolfe MS, Kopan R (2004). Intramembrane proteolysis: theme and variations. Science, 305, 1119-23.
  9. Xu W, Cao L, Chen L, et al (2011). Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy. Clin Cancer Res, 17, 3783-93.
  10. Yan Z, Zou H, Tian F, et al (2008). Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol Cancer Ther, 7, 1355-64.
  11. Yoneda N, Sato Y, Kitao A, et al (2011). Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma. Lab Invest, 91, 262-72.
  12. Zeng QA, Qiu JL, Zou RH, et al (2012). Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study. BMC Cancer, 12.
  13. Zhang JK, Pan PL, Wu YM, et al (2010). [Expression of HER-2/neu oncogene in hepatocellular carcinoma and the clinical implications]. Nan Fang Yi Ke Da Xue Xue Bao, 30, 326-8.
  14. Zou H, Thomas SM, Yan ZW, et al (2009). Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells. Faseb J, 23, 425-32.
  15. Abba MC, Lacunza E, Nunez MI, et al (2009). Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer. Biochim Biophys Acta, 1792, 988-97.
  16. Adrain C, Strisovsky K, Zettl M, et al (2011). Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep, 12, 421-7.
  17. Akiyama Y, Kanehara K, Ito K (2004). RseP (YaeL), an Escherichia coli RIP protease, cleaves transmembrane sequences. Embo J, 23, 4434-42.
  18. Bacaksiz A, Sahin FI, Bilezikci B, et al (2008). Determination of HER-2/Neu status in hepatocellular carcinoma cases. Genet Test, 12, 211-4.
  19. Berasain C, Nicou A, Garcia-Irigoyen O, et al (2012). Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism. Dig Dis, 30, 524-31.
  20. Brown MS, Ye J, Rawson RB, et al (2000). Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell, 100, 391-8.
  21. Chen W, Shen X, Xia X, et al (2012). NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma. Liver Int, 32, 70-7.
  22. De Strooper B, Saftig P, Craessaerts K, et al (1998). Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature, 391, 387-90.
  23. Desbois-Mouthon C, Cacheux W, Blivet-Van Eggelpoel MJ, et al (2006). Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. Int J Cancer, 119, 2557-66.
  24. Ezzoukhry Z, Louandre C, Trecherel E, et al (2012). EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. Int J Cancer, 131, 2961-9.
  25. Freeman M (2008). Rhomboid proteases and their biological functions. Annu Rev Genet, 42, 191-210.
  26. Furuse J (2008). Growth factors as therapeutic targets in HCC. Crit Rev Oncol Hematol, 67, 8-15.
  27. Gao J, Yu Y, Zhang Y, et al (2012). EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials, 33, 270-82.
  28. Ha Y (2009). Structure and mechanism of intramembrane protease. Semin Cell Dev Biol, 20, 240-50.
  29. Howell SA, Hackett F, Jongco AM, et al (2005). Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens. Mol Microbiol, 57, 1342-56.
  30. Kroos L, Yu YT (2000). Regulation of sigma factor activity during Bacillus subtilis development. Curr Opin Microbiol, 3, 553-60.

Cited by

  1. Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth vol.12, pp.1, 2012,
  2. Rhomboid family gene expression profiling in breast normal tissue and tumor samples vol.35, pp.2, 2014,